We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.36B
AUM Growth
+$457M
Cap. Flow
-$178M
Cap. Flow %
-2.42%
Top 10 Hldgs %
26.1%
Holding
2,906
New
66
Increased
422
Reduced
1,573
Closed
124

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.8M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$5.97M
3
EPAM icon
EPAM Systems
EPAM
+$3.35M
4
O icon
Realty Income
O
+$1.92M
5
KRG icon
Kite Realty
KRG
+$1.67M

Top Sells

Rank Stock Value
1
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$18.3M
2
AAPL icon
Apple
AAPL
+$13.9M
3
MSFT icon
Microsoft
MSFT
+$9.44M
4
AMZN icon
Amazon
AMZN
+$5.45M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$5.29M

Sector Composition

Rank Sector Weight
1 Technology 25.69%
2 Consumer Discretionary 12.47%
3 Healthcare 12.1%
4 Financials 11.43%
5 Communication Services 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STTK icon
2826
Shattuck Labs
STTK
$761M
– –
-8,378
Closed -$171K
SYRE icon
2827
Spyre Therapeutics
SYRE
$8.96B
– –
-465
Closed -$92.3K
TXMD icon
2828
TherapeuticsMD
TXMD
$24M
– –
-653
Closed -$24.2K
URGN icon
2829
UroGen Pharma
URGN
$2.38B
– –
-5,563
Closed -$93.6K
VHC icon
2830
VirnetX Holding Corp
VHC
$66.8M
– –
-868
Closed -$68K
VRA icon
2831
Vera Bradley
VRA
$96.1M
– –
-7,298
Closed -$68.7K
XBIT icon
2832
XBiotech
XBIT
$72.3M
– –
-4,457
Closed -$57.7K
ZVRA icon
2833
Zevra Therapeutics
ZVRA
$674M
– –
-3,598
Closed -$33.6K
ZYXI
2834
DELISTED
Zynex
ZYXI
– –
-6,266
Closed -$64.9K
NEUE
2835
DELISTED
NeueHealth
NEUE
– –
-197
Closed -$128K
LENZ
2836
LENZ Therapeutics
LENZ
$155M
– –
-742
Closed -$85.1K
QTTB icon
2837
Q32 Bio
QTTB
$453M
– –
-662
Closed -$93.7K
TECX
2838
Tectonic Therapeutic
TECX
$699M
– –
-259
Closed -$17.4K
NAGE
2839
Niagen Bioscience
NAGE
$245M
– –
-5,355
Closed -$33.6K
SYRS
2840
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– –
-1,642
Closed -$73.4K
VIRX
2841
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-5,766
Closed -$46.2K
NEXI
2842
DELISTED
NexImmune, Inc. Common Stock
NEXI
– –
-233
Closed -$88.2K
AWH
2843
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
– –
-1,316
Closed -$64.1K
CBAY
2844
DELISTED
Cymabay Therapeutics
CBAY
– –
-20,041
Closed -$73.2K
BFX
2845
DELISTED
BowFlex Inc.
BFX
– –
-4,086
Closed -$38K
SIEN
2846
DELISTED
Sientra, Inc.
SIEN
– –
-1,541
Closed -$88.3K
LTRPA
2847
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
– –
-20,420
Closed -$63.1K
EBET
2848
DELISTED
EBET, INC. Common Stock
EBET
– –
-116
Closed -$117K
INFI
2849
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-25,060
Closed -$85.7K
FXLV
2850
DELISTED
F45 Training Holdings Inc.
FXLV
– –
-6,613
Closed -$98.9K
112 113
114
115 116

Similar funds

GWM
Graybill Wealth Management Elmhurst, Illinois $328M AUM 21.42% 1-Year Est. Return
KSCM
King Street Capital Management New York $328M AUM 0.61% 1-Year Est. Return
AFS
Aft Forsyth & Sober Valrico, Florida $328M AUM 25.24% 1-Year Est. Return
BAM
Blueshift Asset Management Red Bank, New Jersey $330M AUM 7.9% 1-Year Est. Return
ML
Maniro Ltd Nassau $330M AUM
ISFAN
Investor's Fiduciary Advisor Network Snoqualmie, Washington $326M AUM 19.7% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return
ECH
ER Collective Holdings Washington, District of Columbia $326M AUM

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 Portfolio in Review

As of Q4 2021, Metropolitan Life Insurance Company (MetLife) held 2,906 positions worth $7.36B, up 6.6% from $6.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 filing shows 66 new, 422 increased, 1,573 reduced and 124 closed positions. Its largest new stake was Kyndryl: 32,951 shares worth $596K. The largest sale was iShares Russell 1000 Growth ETF, an estimated $18.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2021 buy was Kyndryl: 32,951 shares worth $596K.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $34.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $18.3M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Kansas City Southern in Q4 2021, selling an estimated $3.18M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $7.36B portfolio in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 124 in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.6% quarter-over-quarter to $7.36B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.